Tjoa, B A <br/><br/>
Follow-up evaluation of a phase II prostate cancer vaccine trial.  [electronic resource] 

 -  The Prostate  Jul 1999 
 - 125-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-4137 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0045(19990701)40:2<125::aid-pros8>3.0.co;2-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Surface<br/>Cancer Vaccines--therapeutic use<br/>Carboxypeptidases--immunology<br/>Dendritic Cells--immunology<br/>Glutamate Carboxypeptidase II<br/>HLA-A2 Antigen--immunology<br/>Humans<br/>Immunotherapy<br/>Immunotherapy, Adoptive<br/>Leukapheresis<br/>Male<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--immunology